Eventide Asset Management’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-180,000
Closed -$4.03M 141
2017
Q3
$4.03M Hold
180,000
0.23% 83
2017
Q2
$4.37M Hold
180,000
0.27% 74
2017
Q1
$3.45M Hold
180,000
0.23% 83
2016
Q4
$3.52M Hold
180,000
0.23% 79
2016
Q3
$2.85M Hold
180,000
0.17% 87
2016
Q2
$2.54M Hold
180,000
0.16% 93
2016
Q1
$3.03M Hold
180,000
0.17% 90
2015
Q4
$4.04M Sell
180,000
-4,100
-2% -$84.5K 0.2% 94
2015
Q3
$4.03M Buy
184,100
+31,800
+21% +$795K 0.23% 81
2015
Q2
$3.75M Hold
152,300
0.2% 86
2015
Q1
$3.12M Hold
152,300
0.23% 84
2014
Q4
$3.04M Hold
152,300
0.33% 68
2014
Q3
$2.24M Hold
152,300
0.31% 66
2014
Q2
$2.8M Buy
152,300
+8,500
+6% +$141K 0.38% 66
2014
Q1
$2.71M Buy
143,800
+74,500
+108% +$1.53M 0.42% 61
2013
Q4
$1.29M Buy
+69,300
New +$1.01M 0.4% 57

Other funds holding ATRC

Eventide Asset Management's ATRC Position: Q4 2017 in Review

Eventide Asset Management sold out of AtriCure (ATRC) in Q4 2017, closing a stake of 180,000 shares — an estimated $4.03M sold.

Eventide Asset Management first reported a position in ATRC in Q4 2013 and held it in 16 quarters. The position peaked at $4.37M in Q2 2017. 109 funds tracked by Wall St. Rank hold ATRC as of Q4 2017.

  • Eventide Asset Management reported no remaining AtriCure position as of Q4 2017 after selling out during the quarter.
  • Eventide Asset Management sold 180,000 AtriCure shares in Q4 2017, an estimated $4.03M.
  • Eventide Asset Management first reported a position in AtriCure in Q4 2013 and held it in 16 quarters.
  • Eventide Asset Management's AtriCure position peaked at $4.37M in Q2 2017.
  • 109 funds tracked by Wall St. Rank held AtriCure as of Q4 2017.

Based on Eventide Asset Management's 13F filing for Q4 2017, filed 14 Feb 2018.